GlassScriptPhysician profile
Jeffrey C Chen
NPI 1801120191
$12,195.11
in general payments reported to CMS, 2019-2025
40 companies · $2,149 in 2025
The $2,149 reported for 2025 was more than what 87% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,058 · 2020: $689 · 2021: $1,737 · 2022: $1,703 · 2023: $1,819 · 2024: $2,040 · 2025: $2,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,808 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,807.95 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,866.72 | 2019-2025 | Breztri, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $2,352.78 | 2019-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,134.56 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Merck Sharp & Dohme LLC | $602.28 | 2019-2025 | Zerbaxa, Winrevair, Dificid |
| Bayer Healthcare Pharmaceuticals INC. | $588.40 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $566.99 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Genzyme Corporation | $441.78 | 2022-2025 | |
| Genentech USA, INC. | $437.79 | 2019-2020 | |
| Harmony Biosciences LLC | $352.88 | 2020-2024 | Wakix |
| Electromed, INC. | $336.29 | 2022-2025 | Smartvest |
| Verona Pharma, INC. | $290.51 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $257.81 | 2022-2025 | Dupixent |
| Mylan Specialty L.P. | $222.37 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $195.91 | 2019-2024 | Tyvaso, Orenitram |
| Allergan, INC. | $170.03 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $132.48 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $128.11 | 2019 | |
| Abiomed | $125.00 | 2024 | Impella |
| Amgen INC. | $123.61 | 2022-2023 | Tezspire |
| Insmed, INC. | $122.43 | 2022-2024 | Arikayce |
| E.R. Squibb & Sons, L.L.C. | $108.63 | 2019 | |
| Advanced Respiratory, INC | $91.50 | 2021 | |
| Viatris Specialty LLC | $81.36 | 2025 | Yupelri |
| Pulmonx Corporation | $76.79 | 2021 | |
| Boston Scientific Corporation | $46.70 | 2019-2025 | Intracept |
| Sunovion Pharmaceuticals INC. | $39.38 | 2019 | |
| Paratek Pharmaceuticals, INC. | $33.77 | 2024 | Nuzyra |
| Janssen Pharmaceuticals, INC | $30.49 | 2020-2022 | |
| Shionogi INC | $30.16 | 2023 | Fetroja |
| Baxter Healthcare | $27.69 | 2023-2024 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $24.75 | 2024 | (Ak6) Vest Therapy |
| Mallinckrodt Enterprises LLC | $24.41 | 2019 | |
| Grifols USA, LLC | $22.17 | 2024 | Prolastin-C Liquid |
| Lilly USA, LLC | $20.03 | 2025 | Zepbound, Mounjaro |
| Sanofi Pasteur INC. | $19.62 | 2024 | |
| Mallinckrodt Hospital Products INC. | $15.87 | 2022 | |
| Piramal Critical Care | $15.44 | 2020 | |
| Pfizer INC. | $13.88 | 2019 | |
| Circassia INC. | $12.32 | 2020 | |
| Gilead Sciences, INC. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.